Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Food and Drug Administration approval of cetuximab and a new KRAS genetic test for metastatic colorectal cancer: major advance but just the tip of the biomarker iceberg.

× No keyword cloud information.

4 in total

1. An updated scoring system for prediction of survival after resection of colorectal liver metastases: addition of KRAS status as an important risk modifier.

Authors: Evan Jost; Don Major; Elijah Dixon
Journal: Hepatobiliary Surg Nutr Date: 2020-02 Impact factor: 7.293

Review 2. New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Authors: Giuseppe Bronte; Nicola Silvestris; Marta Castiglia; Antonio Galvano; Francesco Passiglia; Giovanni Sortino; Giuseppe Cicero; Christian Rolfo; Marc Peeters; Viviana Bazan; Daniele Fanale; Antonio Giordano; Antonio Russo
Journal: Oncotarget Date: 2015-09-22

3. Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.

Authors: B Englinger; M Mair; W Miklos; C Pirker; T Mohr; S van Schoonhoven; D Lötsch; W Körner; F Ferk; S Knasmüller; P Heffeter; B K Keppler; M Grusch; W Berger
Journal: Br J Cancer Date: 2017-01-17 Impact factor: 7.640

4. HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.

Authors: Said A Khelwatty; Soozana Puvanenthiran; Sharadah Essapen; Izhar Bagwan; Alan M Seddon; Helmout Modjtahedi
Journal: Cancers (Basel) Date: 2021-02-05 Impact factor: 6.639

4 in total